Cannabis-derived compound may help treat schizophrenia

New research paves the way for a new schizophrenia treatment, by testing the effect of a cannabis compound on rats. The study suggests that the cannabis-derived substance may improve schizophrenia-specific cognitive impairment, with none of the side effects that current medication has.

A new study shows how cannabis-derived CBD can improve schizophrenia-like symptoms in rats.

Schizophrenia affects about 1.1 percent of the American population – or approximately 3.5 million adults.

The symptoms of schizophrenia are wide-ranging and varied. They include so-called positive symptoms – that is, symptoms that do not appear in healthy individuals – negative symptoms, called negative because they are a disruption to normal behavior, and finally, cognitive symptoms.

The latter category includes difficulty paying attention or concentrating, trouble making decisions, as well as problems with comprehending and using new information.

While currently available medication effectively treats positive symptoms – such as hallucinations and

... read more at: http://www.medicalnewstoday.com/articles/317768.php

Leave a Reply

Your email address will not be published. Required fields are marked *